BEAM Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 4.20%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $10,445,723.95

Beam Therapeutics Insider Trading History Chart

Beam Therapeutics Share Price & Price History

^$25.05

▲ +1.47 (6.23%)

As of 11/22/2024 01:00 AM ET

Days: 30 | 90 | 365

This company will win the AI race

From Porter & Company | Ad

Rome wasn’t built in a day… But there is another lesser-known type of keystone, one that plays an equally critical role in supporting the most revolutionary technology the world’s ever seen… artificial intelligence. And without it, the entire AI industry would collapse.

You must read this new presentation from Porter Stansberry.

Beam Therapeutics Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
11/6/2024	Giuseppe Ciaramella	President	Sell	51,110	$26.36	$1,347,259.60	109,150
10/14/2024	Giuseppe Ciaramella	President	Sell	51,110	$26.27	$1,342,659.70	160,260
10/1/2024	Bethany J Cavanagh	SVP	Sell	289	$23.48	$6,785.72	44,931
10/1/2024	Christine Bellon	Insider	Sell	385	$23.48	$9,039.80	104,209
9/30/2024	John M Evans	CEO	Sell	60,000	$24.60	$1,476,000.00	938,659
7/1/2024	Amy Simon	Insider	Sell	502	$23.76	$11,927.52	69,553
6/27/2024	John M Evans	CEO	Sell	60,000	$24.50	$1,470,000.00	998,343
4/1/2024	Amy Simon	Insider	Sell	7,157	$32.13	$229,954.41	86,590
4/1/2024	Giuseppe Ciaramella	President	Sell	4,534	$32.12	$145,632.08	169,616
4/1/2024	John M Evans	CEO	Sell	18,102	$32.13	$581,617.26	1,058,343
4/1/2024	Terry-Ann Burrell	CFO	Sell	5,446	$32.12	$174,925.52	70,137
3/28/2024	John M Evans	CEO	Sell	60,000	$33.86	$2,031,600.00	998,262
2/13/2024	Fmr Llc	Insider	Sell	1,565	$30.76	$48,139.40	2,771,913
1/31/2024	John M Evans	CEO	Sell	60,000	$25.33	$1,519,800.00	1,058,262
1/3/2024	Christine Bellon	Insider	Sell	1,907	$26.42	$50,382.94	80,495
10/30/2023	Amy Simon	Insider	Sell	3,448	$18.70	$64,477.60	65,469
10/2/2023	Christine Bellon	Insider	Sell	388	$22.85	$8,865.80	82,402
7/24/2023	Giuseppe Ciaramella	Insider	Sell	1,206	$32.01	$38,604.06	48,250
7/21/2023	Giuseppe Ciaramella	Insider	Sell	155,324	$32.06	$4,979,687.44	48,250
7/10/2023	Amy Simon	Insider	Sell	391	$30.48	$11,917.68	68,917
4/3/2023	Giuseppe Ciaramella	Insider	Sell	1,918	$30.31	$58,134.58	114,044
4/3/2023	John M Evans	CEO	Sell	5,161	$30.31	$156,429.91	1,124,472
4/3/2023	Terry-Ann Burrell	CFO	Sell	2,454	$30.31	$74,380.74	49,303
1/26/2023	Terry-Ann Burrell	CFO	Sell	1,102	$45.16	$49,766.32	31,277
1/24/2023	Terry-Ann Burrell	CFO	Sell	14,810	$45.01	$666,598.10	31,277
1/18/2023	Terry-Ann Burrell	CFO	Sell	47,195	$45.14	$2,130,382.30	31,277
12/12/2022	Giuseppe Ciaramella	Insider	Sell	51,015	$42.70	$2,178,340.50	91,462
10/31/2022	John M Evans	CEO	Sell	30,000	$46.31	$1,389,300.00	1,058,520
8/5/2022	Fmr Llc	Insider	Sell	20,326	$60.50	$1,229,723.00
7/28/2022	John M Evans	CEO	Sell	30,000	$65.75	$1,972,500.00	1,088,520
4/28/2022	John M Evans	CEO	Sell	30,000	$37.98	$1,139,400.00	1,118,520
4/13/2022	Fmr Llc	Insider	Sell	19,466	$50.41	$981,281.06
3/31/2022	Giuseppe Ciaramella	Insider	Sell	1,859	$59.11	$109,885.49	115,614
3/31/2022	John M Evans	CEO	Sell	6,261	$59.11	$370,087.71	1,089,070
3/31/2022	Terry-Ann Burrell	CFO	Sell	1,787	$59.11	$105,629.57	38,278
12/21/2021	Giuseppe Ciaramella	Insider	Sell	25,104	$85.69	$2,151,161.76

This company will win the AI race

From Porter & Company | Ad

You must read this new presentation from Porter Stansberry.

SEC Filings (Institutional Ownership Changes) for Beam Therapeutics (NASDAQ:BEAM)

99.68% of Beam Therapeutics stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

Beam Therapeutics Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/16/2024	Geode Capital Management LLC	1,807,683	$44.30M	0.0%	+4.5%	2.183%
11/15/2024	XTX Topco Ltd	37,001	$0.91M	0.1%	+16.3%	0.045%
11/15/2024	Wellington Management Group LLP	38,996	$0.96M	0.0%	-9.5%	0.047%
11/15/2024	State Street Corp	3,929,557	$96.27M	0.0%	+12.5%	4.745%
11/15/2024	Stifel Financial Corp	10,686	$0.26M	0.0%	N/A	0.013%
11/15/2024	Quarry LP	6,000	$0.15M	0.0%	+66.7%	0.007%
11/15/2024	Redmile Group LLC	1,611,013	$39.47M	2.3%	-5.4%	1.945%
11/15/2024	Polar Asset Management Partners Inc.	20,800	$0.51M	0.0%	N/A	0.025%
11/15/2024	Benjamin Edwards Inc.	16,315	$0.40M	0.0%	+10,998.6%	0.020%
11/15/2024	Erste Asset Management GmbH	21,700	$0.54M	0.0%	N/A	0.026%
11/14/2024	Bellevue Group AG	1,518,121	$37.19M	0.6%	+7.1%	1.833%
11/14/2024	Verition Fund Management LLC	15,024	$0.37M	0.0%	N/A	0.018%
11/14/2024	Walleye Capital LLC	127,588	$3.13M	0.0%	+21.6%	0.154%
11/14/2024	Martingale Asset Management L P	10,529	$0.26M	0.0%	+17.9%	0.013%
11/14/2024	UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC	401,286	$9.83M	0.0%	-4.4%	0.485%
11/14/2024	Zurcher Kantonalbank Zurich Cantonalbank	21,396	$0.52M	0.0%	+2.5%	0.026%
11/13/2024	FMR LLC	4,211,517	$103.18M	0.0%	-4.5%	5.086%
11/13/2024	D.A. Davidson & CO.	53,847	$1.32M	0.0%	+8.5%	0.065%
11/13/2024	The Manufacturers Life Insurance Company	145,851	$3.57M	0.0%	+6.4%	0.176%
11/13/2024	Horizon Kinetics Asset Management LLC	9,194	$0.23M	0.0%	-4.2%	0.011%
11/12/2024	Algert Global LLC	43,523	$1.07M	0.0%	+282.0%	0.053%
11/12/2024	Charles Schwab Investment Management Inc.	629,492	$15.42M	0.0%	+6.1%	0.760%
11/12/2024	Massachusetts Financial Services Co. MA	57,698	$1.41M	0.0%	-2.4%	0.070%
11/9/2024	Intech Investment Management LLC	20,892	$0.51M	0.0%	N/A	0.025%
11/7/2024	Quest Partners LLC	36,193	$0.89M	0.1%	+410.8%	0.044%
11/5/2024	Victory Capital Management Inc.	9,093	$0.22M	0.0%	-8.3%	0.011%
11/5/2024	Sumitomo Mitsui Trust Group Inc.	3,552,829	$87.04M	0.1%	+59.7%	4.311%
11/5/2024	Baillie Gifford & Co.	357,698	$8.76M	0.0%	-42.6%	0.434%
11/1/2024	Atria Investments Inc	8,167	$0.20M	0.0%	N/A	0.010%
10/31/2024	ARK Investment Management LLC	6,531,099	$160.01M	1.5%	-14.4%	7.925%
10/29/2024	Arcadia Investment Management Corp MI	4,000	$98K	0.0%	N/A	0.005%
10/25/2024	China Universal Asset Management Co. Ltd.	16,087	$0.39M	0.0%	+62.4%	0.020%
10/23/2024	Mirae Asset Global Investments Co. Ltd.	2,981	$75K	0.0%	+21.3%	0.004%
10/22/2024	International Assets Investment Management LLC	64,313	$15.76M	0.0%	N/A	0.078%
10/18/2024	Blue Trust Inc.	3,135	$73K	0.0%	+84.0%	0.004%
10/16/2024	IQ EQ FUND MANAGEMENT IRELAND Ltd	13,118	$0.32M	0.0%	+41.0%	0.016%
10/11/2024	Creative Planning	11,946	$0.29M	0.0%	+25.5%	0.014%
10/7/2024	Green Alpha Advisors LLC	12,475	$0.31M	0.2%	+5.9%	0.015%
10/7/2024	GAMMA Investing LLC	4,620	$0.11M	0.0%	+13.3%	0.006%
10/5/2024	Handelsbanken Fonder AB	28,500	$0.70M	0.0%	+61.9%	0.035%
10/3/2024	SG Americas Securities LLC	10,147	$0.25M	0.0%	-47.0%	0.012%
8/16/2024	Quarry LP	3,600	$84K	0.0%	+350.0%	0.004%
8/16/2024	Algert Global LLC	11,393	$0.27M	0.0%	N/A	0.014%
8/15/2024	Scientech Research LLC	51,876	$1.22M	0.3%	+167.3%	0.063%
8/15/2024	The Manufacturers Life Insurance Company	137,089	$3.21M	0.0%	+30.8%	0.167%
8/15/2024	AQR Capital Management LLC	9,011	$0.21M	0.0%	+38.1%	0.011%
8/14/2024	Squarepoint Ops LLC	9,314	$0.22M	0.0%	-83.1%	0.011%
8/14/2024	ARCH Venture Management LLC	5,443,039	$127.53M	46.5%	N/A	6.613%
8/14/2024	Farallon Capital Management LLC	7,913,123	$185.40M	0.9%	+75.4%	9.614%
8/14/2024	Bank of Montreal Can	151,066	$3.68M	0.0%	N/A	0.184%
8/14/2024	ProShare Advisors LLC	15,072	$0.35M	0.0%	-22.8%	0.018%
8/14/2024	Profund Advisors LLC	30,868	$0.72M	0.0%	-20.1%	0.038%
8/13/2024	Benjamin F. Edwards & Company Inc.	18,982	$0.45M	0.0%	+4,843.2%	0.023%
8/12/2024	XTX Topco Ltd	31,810	$0.75M	0.1%	N/A	0.039%
8/12/2024	Hsbc Holdings PLC	14,341	$0.33M	0.0%	N/A	0.017%
8/12/2024	Mercer Global Advisors Inc. ADV	16,011	$0.38M	0.0%	-7.3%	0.019%
8/12/2024	E Fund Management Co. Ltd.	10,037	$0.24M	0.0%	-13.1%	0.012%
8/9/2024	Dimensional Fund Advisors LP	1,049,360	$24.59M	0.0%	+63.5%	1.275%
8/9/2024	Massachusetts Financial Services Co. MA	59,095	$1.39M	0.0%	N/A	0.072%
8/9/2024	Fairfield Financial Advisors LTD	1,105	$26K	0.0%	N/A	0.001%
8/8/2024	Federated Hermes Inc.	20,839	$0.49M	0.0%	N/A	0.025%
8/8/2024	American Century Companies Inc.	95,578	$2.24M	0.0%	+33.2%	0.116%
8/6/2024	Quest Partners LLC	7,085	$0.17M	0.0%	+43.0%	0.009%
8/6/2024	Los Angeles Capital Management LLC	16,787	$0.39M	0.0%	-6.2%	0.020%
8/5/2024	Arizona State Retirement System	19,431	$0.46M	0.0%	+2.1%	0.024%
8/5/2024	Victory Capital Management Inc.	9,921	$0.23M	0.0%	+10.9%	0.012%
8/3/2024	National Bank of Canada FI	3,000	$69K	0.0%	+200.0%	0.004%
8/3/2024	TD Asset Management Inc	175,892	$4.12M	0.0%	+8.1%	0.214%
8/1/2024	Rhumbline Advisers	132,569	$3.11M	0.0%	+21.6%	0.161%
7/29/2024	Principal Financial Group Inc.	10,400	$0.24M	0.0%	-43.5%	0.013%
7/29/2024	IQ EQ FUND MANAGEMENT IRELAND Ltd	9,303	$0.22M	0.0%	N/A	0.011%
7/26/2024	ARK Investment Management LLC	7,626,139	$178.68M	1.6%	-6.8%	9.265%
7/26/2024	Liontrust Investment Partners LLP	80,000	$1.87M	0.0%	N/A	0.097%
7/26/2024	Bank of New York Mellon Corp	287,569	$6.74M	0.0%	-0.8%	0.349%
7/25/2024	Baillie Gifford & Co.	623,640	$14.61M	0.0%	-17.1%	0.758%
7/22/2024	Krilogy Financial LLC	51,336	$1.20M	0.1%	+52.8%	0.062%
7/19/2024	Sumitomo Mitsui Trust Holdings Inc.	2,224,415	$52.12M	0.0%	-5.8%	2.702%
7/18/2024	Blue Trust Inc.	1,704	$40K	0.0%	+2,648.4%	0.002%
7/17/2024	SteelPeak Wealth LLC	17,795	$0.42M	0.0%	+137.1%	0.022%
7/12/2024	SG Americas Securities LLC	19,142	$0.45M	0.0%	+212.6%	0.023%
7/12/2024	QRG Capital Management Inc.	21,230	$0.50M	0.0%	-7.8%	0.026%
7/2/2024	GAMMA Investing LLC	4,076	$96K	0.0%	+958.7%	0.005%
5/24/2024	Farallon Capital Management LLC	4,511,753	$149.07M	0.7%	+9.9%	5.481%
5/20/2024	Virtu Financial LLC	26,486	$0.88M	0.1%	N/A	0.032%
5/16/2024	California State Teachers Retirement System	69,814	$2.31M	0.0%	-2.9%	0.085%
5/16/2024	Bayesian Capital Management LP	8,803	$0.29M	0.0%	N/A	0.011%
5/16/2024	Redmile Group LLC	1,879,617	$62.10M	2.3%	+31.5%	2.284%
5/15/2024	Darwin Global Management Ltd.	2,119,598	$70.03M	9.5%	N/A	2.575%
5/15/2024	Bellevue Group AG	1,193,121	$39.42M	0.6%	+71.7%	1.450%
5/15/2024	Bamco Inc. NY	30,000	$0.99M	0.0%	N/A	0.036%
5/15/2024	Price T Rowe Associates Inc. MD	1,246,189	$41.18M	0.0%	+3,137.7%	1.514%
5/15/2024	Lazard Asset Management LLC	55,093	$1.82M	0.0%	-5.8%	0.067%
5/14/2024	American International Group Inc.	36,760	$1.22M	0.0%	+2.0%	0.045%
5/10/2024	Vanguard Group Inc.	7,578,768	$250.40M	0.0%	+5.8%	9.208%
5/8/2024	ProShare Advisors LLC	19,511	$0.65M	0.0%	+10.6%	0.024%
5/8/2024	Russell Investments Group Ltd.	143,828	$4.75M	0.0%	+4.4%	0.175%
5/8/2024	QRG Capital Management Inc.	23,036	$0.76M	0.0%	+45.2%	0.028%
5/7/2024	Reynders McVeigh Capital Management LLC	6,055	$0.20M	0.0%	N/A	0.007%
5/7/2024	Swiss National Bank	136,700	$4.52M	0.0%	+3.1%	0.166%
5/7/2024	SG Americas Securities LLC	6,124	$0.20M	0.0%	-58.7%	0.007%

Data available starting January 2016

Beam Therapeutics Inc., a biotechnology company, engages in the development of precision genetic medicines for patients suffering from serious diseases in the United States. It develops BEAM-101 for the treatment of sickle cell disease or beta-thalassemia; and BEAM-302, a liver-targeting LNP formulation to treat severe alpha-1 antitrypsin deficiency; BEAM-201, an anti-CD7 CAR-T product candidate, which is in Phase 1/2 clinical trials for the treatment of refractory T-cell acute lymphoblastic leukemia/T cell lymphoblastic lymphoma; and BEAM-301, a liver-targeting LNP formulation for the treatment of glycogen storage disease 1a. The company has research collaboration agreement with Pfizer Inc., focus on in vivo base editing programs for targets rare genetic diseases of the liver, muscle, and central nervous system; Apellis Pharmaceuticals to conduct preclinical research on target specific genes within the complement system in various organs, including the eye, liver, and brain; Verve Therapeutics, Inc., for cardiovascular disease treatments; Sana Biotechnology, Inc., to research, develop, and commercialize rights to CRISPR Cas12b for cell therapy programs; and Orbital Therapeutics design RNA for the prevention, treatment or diagnosis of human disease. Beam Therapeutics Inc. was incorporated in 2017 and is based in Cambridge, Massachusetts.

Today's Range

Now: $25.05

$23.18

$25.43

50 Day Range

MA: $24.51

$21.55

$30.35

52 Week Range

Now: $25.05

$20.84

$49.50

Volume

1,187,300 shs

Average Volume

1,235,537 shs

Market Capitalization

$2.07 billion

P/E Ratio

N/A

Dividend Yield

N/A

Beta

1.86

Who are the company insiders with the largest holdings of Beam Therapeutics?: Beam Therapeutics' top insider investors include:
Fmr Llc (Insider)
John M Evans (CEO)
Giuseppe Ciaramella (President)
Giuseppe Ciaramella (Insider)
Christine Bellon (Insider)
Amy Simon (Insider)
Terry-Ann Burrell (CFO)
Bethany J Cavanagh (SVP)
Learn More about top insider investors at Beam Therapeutics.
Who are the major institutional investors of Beam Therapeutics?: Beam Therapeutics' top institutional shareholders include:
ARK Investment Management LLC — 7.92%
FMR LLC — 5.09%
State Street Corp — 4.75%
Sumitomo Mitsui Trust Group Inc. — 4.31%
Geode Capital Management LLC — 2.18%
Redmile Group LLC — 1.95%
Learn More about top institutional investors of Beam Therapeutics stock.
Which institutional investors are selling Beam Therapeutics stock?: During the previous quarter, BEAM stock was sold by these institutional investors:
ARK Investment Management LLC
Baillie Gifford & Co.
FMR LLC
Redmile Group LLC
UBS AM a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC
SG Americas Securities LLC
Wellington Management Group LLP
Massachusetts Financial Services Co. MA
In the last year, company insiders that have sold Beam Therapeutics company stock include:
Fmr Llc (Insider)
John M Evans (CEO)
Giuseppe Ciaramella (President)
Giuseppe Ciaramella (Insider)
Christine Bellon (Insider)
Amy Simon (Insider)
Terry-Ann Burrell (CFO)
Learn More investors selling Beam Therapeutics stock.
Which institutional investors are buying Beam Therapeutics stock?: In the previous quarter, BEAM stock was bought by institutional investors including:
Sumitomo Mitsui Trust Group Inc.
State Street Corp
Bellevue Group AG
Geode Capital Management LLC
International Assets Investment Management LLC
Charles Schwab Investment Management Inc.
Algert Global LLC
Barclays PLC